Headquarters
11629 105 AVE NW, EDMONTON, AB T5H 0L9, CA
EDMONTON, AB, CA
From the company
Fedora Pharmaceuticals Inc. is a Canadian clinical-stage biotechnology company based in Edmonton, Alberta, founded in 2011. It discovers and develops novel antibacterial therapies to combat antimicrobial resistance (AMR). Its pipeline includes nacubactam, a β-lactamase inhibitor/enhancer, and FPI-2119, a first-in-class non-β-lactam penicillin-binding protein inhibitor. The company's team also discovered tazobactam.
11629 105 AVE NW, EDMONTON, AB T5H 0L9, CA
Quantities, certifications, and timing.